Gene edit­ing start­up Scribe Ther­a­peu­tics lets go of staff as it preps for the clin­ic

Scribe Ther­a­peu­tics, a biotech co-found­ed by CRISPR pi­o­neer Jen­nifer Doud­na, is re­duc­ing its work­force by about 20%, the com­pa­ny con­firmed to End­points News.

CEO Ben …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.